
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries